Hallucinations Associated with Topiramate Therapy: A Case Report and Review of the Literature.

CONCLUSION: This case supports the previous reports describing the associoation between the use of topiramate and the developmenrt of hallucinations. Even though the average daily topiramate dose associated with the development of hallucinations in previously reported cases was 150 mg in women and 181.25 mg in men, hallucinations can occur at lower doses (as low as 50 mg daily) as well.
PMID: 28699493 [PubMed - as supplied by publisher]

Source: Current Drug Safety - July 10, 2017 Category: Drugs & Pharmacology Authors: Register SL, Ruano OL, Sanchez DL, Catalano G, Catalano MC Tags: Curr Drug Saf Source Type: research